Theseus Pharmaceuticals
Stock Forecast, Prediction & Price Target
Theseus Pharmaceuticals Financial Estimates
Theseus Pharmaceuticals Revenue Estimates
Theseus Pharmaceuticals EBITDA Estimates
Theseus Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-11.99M N/A | $-27.30M -127.62% | $-47.08M -72.40% | Avg: $-88.55M Low: $-94.68M High: $-23.86M avg. -88.08% | |||
EBITDA
% change YoY
| $-6.83M N/A | $-27.33M -299.97% | $-54.08M -97.87% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$0.47 N/A | -$2.84 -504.25% | -$1.22 57.04% | Avg: -$1.5 Low: -$2.46 High: -$0.62 avg. -23.08% | |||
Operating Expenses
% change YoY
| $6.83M N/A | $27.33M 299.88% | $54.08M 97.85% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Theseus Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -88.08% in 2025-2025.
We have gathered data from 6 analysts. Their low estimate is -94.68M, average is -88.55M and high is -23.86M.
What is Theseus Pharmaceuticals stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Theseus Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -23.08% in 2025-2025.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$2.46, average is -$1.5 and high is $-0.62.
What is the best performing analyst?
In the last twelve months analysts have been covering Theseus Pharmaceuticals stock. The most successful analyst is Andrew Fein.